Miracle drug or mystery

We just received this note:

As you may have heard over the past 24 hours, phase 2 clinical trial results have shown that a new drug “slowed ALS progression in a statistically meaningful and clinically relevant way.”

The ALS Association, which supported the development of AMX0035, writes that it “could mean the difference between a person with ALS being able to feed themselves versus being fed, or the difference between needing a wheelchair versus not needing one.”

AMX0035 is an oral therapy dissolved in water and is considered safe. It is not available to the public because it has not yet undergone a phase 3 trial.

The ALS Association and I AM ALS have created a petition to ask the FDA and drugmaker to forgo the phase 3 trial and make it available to people living with ALS as soon as possible

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept that my given data and my IP address is sent to a server in the USA only for the purpose of spam prevention through the Akismet program.More information on Akismet and GDPR.

August 30,2020

August 30, 2020

Updated by Dr

September 10, 2020